Zydus receives USFDA approval to initiate Phase II clinical trial of ZYIL1 for Parkinson’s disease Read more
SPARC completes enrolment in PROSEEK, Phase 2 study of Vodobatinib in early Parkinson’s disease Read more
Amneal Parkinson’s drug IPX203 needs to compete with novel subcutaneous levodopa delivery systems post FDA CRL: GlobalData Read more
Urgent need for disease-modifying drugs to arrest Parkinson’s disease progression: GlobalData Read more
Scientists at IIT Madras identify energy deficiency in brain cells as major cause for Parkinson’s Disease Read more
Zydus Cadila gets tentative US FDA approval for Carbidopa and Levodopa extended-release capsules Read more